Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
British Journal of Cancer|February 25, 2009
Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II studyT André, J M Reyes-Vidal, L Fartoux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup studyA de Gramont, J F Bosset, C Milan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)C Louvet, T André, P Hammel, et al.
European Journal of Cancer (Oxford, England : 1990)|May 4, 2001
High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)F Maindrault-Goebel, A de Gramont, C Louvet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2013
Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR studyS Watson, P Validire, P Cervera, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 1, 1997
Long-term follow-up after adjuvant chemotherapy in completely resected early stage ovarian carcinomaE Raymond, Y Drolet, L Marpeau, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1988
High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancerA De Gramont, M Krulik, J Cady, et al.
The Journal of Infusional Chemotherapy|January 1, 1996
Dual modulation of 5-fluorouracil with folinic acid and hydroxyurea in metastatic colorectal cancerA de Gramont, C Louvet, M Bennamoun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2006
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR studyT André, C Tournigand, L Mineur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 studyF-C Bidard, C Tournigand, T André, et al.
Pageof 13